TY - JOUR
T1 - CDH23 mutation and phenotype heterogeneity
T2 - A profile of 107 diverse families with Usher syndrome and nonsyndromic deafness
AU - Astuto, L. M.
AU - Bork, J. M.
AU - Weston, M. D.
AU - Askew, J. W.
AU - Fields, R. R.
AU - Orten, D. J.
AU - Ohliger, S. J.
AU - Riazuddin, S.
AU - Morell, R. J.
AU - Khan, S.
AU - Riazuddin, S.
AU - Kremer, H.
AU - Van Hauwe, P.
AU - Moller, C. G.
AU - Cremers, C. W.R.J.
AU - Ayuso, C.
AU - Heckenlively, J. R.
AU - Rohrschneider, K.
AU - Spandau, U.
AU - Greenberg, J.
AU - Ramesar, R.
AU - Reardon, W.
AU - Bitoun, P.
AU - Millan, J.
AU - Legge, R.
AU - Friedman, T. B.
AU - Kimberling, W. J.
N1 - Funding Information:
We would like to thank all the patients and families, for their participation in the Usher syndrome and recessive nonsyndromic-deafness research projects, and the physicians, including Drs. Martini and Iannoccone, for referring families to us. We would like to thank Dr. Rocky Young at Texas Tech University, for ERG testing of two patients with mutations in DFNB12, and Dr. Ed Cohn, for his advice and contribution. We also would like to recognize Mehdi Sadeghi, for helping to collect Swedish clinical information; Zubair Ahmed, for genotyping the Pakistani families; and Edward Wilcox, for his contributions. This work was supported in part by National Institutes of Health grant P01 DC01813, National Institute on Deafness and Other Communication Disorders grants R01 DC00677-07, and a Foundation Fighting Blindness grant (all to W.J.K.); National Institutes of Health grant P60 DC00982 (to L.M.A.); the University Grants Commission, Islamabad, Pakistan (support to S.K. and S.R.); National Institute on Deafness and Other Communication Disorders/National Institutes of Health intramural funds 1Z01 DC000035-05 and 1Z01 DC000039-05 (both to T.B.F.); a Research to Prevent Blindness Clinician-Scientist Award (to J.R.H.); and the Mgr Van Overbeek Foundation, De Drie Lichten, and De Gelderse Blinden Verneniging (support to C.W.R.J.C. and H.K.).
PY - 2002
Y1 - 2002
N2 - Usher syndrome type I is characterized by congenital hearing loss, retinitis pigmentosa (RP), and variable vestibular areflexia. Usher syndrome type ID, one of seven Usher syndrome type I genetic localizations, have been mapped to a chromosomal interval that overlaps with a nonsyndromic-deafness localization, DFNB12. Mutations in CDH23, a gene that encodes a putative cell-adhesion protein with multiple cadherin-like domains, are responsible for both Usher syndrome and DFNB12 nonsyndromic deafness. Specific CDH23 mutational defects have been identified that differentiate these two phenotypes. Only missense mutations of CDH23 have been observed in families with nonsyndromic deafness, whereas nonsense, frameshift, splice-site, and missense mutations have been identified in families with Usher syndrome. In the present study, a panel of 69 probands with Usher syndrome and 38 probands with recessive nonsyndromic deafness were screened for the presence of mutations in the entire coding region of CDH23, by heteroduplex, single-strand conformation polymorphism, and direct sequence analyses. A total of 36 different CDH23 mutations were detected in 45 families; 33 of these mutations were novel, including 18 missense, 3 nonsense, 5 splicing defects, 5 microdeletions, and 2 insertions. A total of seven mutations were common to more than one family. Numerous exonic and intronic polymorphisms also were detected. Results of ophthalmologic examinations of the patients with nonsyndromic deafness have found asymptomatic RP-like manifestations, indicating that missense mutations may have a subtle effect in the retina. Furthermore, patients with mutations in CDH23 display a wide range of hearing loss and RP phenotypes, differing in severity, age at onset, type, and the presence or absence of vestibular areflexia.
AB - Usher syndrome type I is characterized by congenital hearing loss, retinitis pigmentosa (RP), and variable vestibular areflexia. Usher syndrome type ID, one of seven Usher syndrome type I genetic localizations, have been mapped to a chromosomal interval that overlaps with a nonsyndromic-deafness localization, DFNB12. Mutations in CDH23, a gene that encodes a putative cell-adhesion protein with multiple cadherin-like domains, are responsible for both Usher syndrome and DFNB12 nonsyndromic deafness. Specific CDH23 mutational defects have been identified that differentiate these two phenotypes. Only missense mutations of CDH23 have been observed in families with nonsyndromic deafness, whereas nonsense, frameshift, splice-site, and missense mutations have been identified in families with Usher syndrome. In the present study, a panel of 69 probands with Usher syndrome and 38 probands with recessive nonsyndromic deafness were screened for the presence of mutations in the entire coding region of CDH23, by heteroduplex, single-strand conformation polymorphism, and direct sequence analyses. A total of 36 different CDH23 mutations were detected in 45 families; 33 of these mutations were novel, including 18 missense, 3 nonsense, 5 splicing defects, 5 microdeletions, and 2 insertions. A total of seven mutations were common to more than one family. Numerous exonic and intronic polymorphisms also were detected. Results of ophthalmologic examinations of the patients with nonsyndromic deafness have found asymptomatic RP-like manifestations, indicating that missense mutations may have a subtle effect in the retina. Furthermore, patients with mutations in CDH23 display a wide range of hearing loss and RP phenotypes, differing in severity, age at onset, type, and the presence or absence of vestibular areflexia.
UR - http://www.scopus.com/inward/record.url?scp=18444366182&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=18444366182&partnerID=8YFLogxK
U2 - 10.1086/341558
DO - 10.1086/341558
M3 - Article
C2 - 12075507
AN - SCOPUS:18444366182
VL - 71
SP - 262
EP - 275
JO - American Journal of Human Genetics
JF - American Journal of Human Genetics
SN - 0002-9297
IS - 2
ER -